LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Capsaicin-Decorated Semiconducting Polymer Nanoparticles for Light-Controlled Calcium-Overload/Photodynamic Combination Therapy.

Photo by utumporn_429695_gemstones from unsplash

Calcium-overload cancer therapy has gained more and more attention owing to its good therapeutic efficacy with low side effect. However, conventional calcium-overload therapy is achieved by introducing an additional calcium… Click to show full abstract

Calcium-overload cancer therapy has gained more and more attention owing to its good therapeutic efficacy with low side effect. However, conventional calcium-overload therapy is achieved by introducing an additional calcium element into the tumor site by nanomedicines, which may also lead to the calcium-overload of normal organs, causing an undesirable side effect. To address such issues, capsaicin-decorated semiconducting polymer nanoparticles (CSPN) are designed to modulate the calcium ion channel of cancer cells for calcium-overload cancer therapy without adding an additional calcium element. CSPN is composed of a near-infrared (NIR) absorbing semiconducting polymer (SP) PCPDTBT and a capsaicin-conjugated amphiphilic copolymer, PEG-PHEMA-Cap. Under NIR laser irradiation, PCPDTBT can generate singlet oxygen (1 O2 ), which not only triggers the release of capsaicin, but also induces photodynamic therapy (PDT). The released capsaicin can further activate transient receptor potential cation channel subfamily V member 1 (TRPV1) of U373 cancer cells, leading to an influx of calcium ions into cells. In addition, the intense NIR-II fluorescence signal of CSPN makes it suitable for tumor imaging. Thus, this study develops a tumor specific nanotheranostic system for NIR-II fluorescence imaging-guided calcium-overload/PDT combination therapy.

Keywords: calcium; calcium overload; semiconducting polymer; therapy; capsaicin

Journal Title: Small
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.